CompletedPhase 2NCT00044954
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Texas Southwestern Medical Center
- Principal Investigator
- Robert H. Collins, MDSimmons Cancer Center
- Intervention
- therapeutic allogeneic lymphocytes(biological)
- Eligibility
- 18-75 years · All sexes
- Timeline
- 1999 – 2006
Study locations (14)
- Rocky Mountain Cancer Centers - Denver Midtown, Denver, Colorado, United States
- Florida Hospital Cancer Institute, Orlando, Florida, United States
- Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia, United States
- Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States
- Kansas City Cancer Centers - Central, Kansas City, Missouri, United States
- Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
- St. Joseph's Hospital and Medical Center, Paterson, New Jersey, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States
- Cancer Institute at Oregon Health and Science University, Portland, Oregon, United States
- Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville, Tennessee, United States
- Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
- Texas Transplant Institute, San Antonio, Texas, United States
- Massey Cancer Center at Virginia Commonwealth University, Richmond, Virginia, United States
- University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00044954 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.